SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 34 filers reported holding SEELOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,402 | -82.8% | 56,533 | +11.9% | 0.00% | -88.9% |
Q2 2023 | $60,348 | +18.5% | 50,500 | -31.5% | 0.01% | +50.0% |
Q1 2023 | $50,937 | -7.6% | 73,693 | -6.1% | 0.01% | +50.0% |
Q4 2022 | $55,126 | +67.0% | 78,493 | +47.5% | 0.00% | +100.0% |
Q1 2022 | $33,000 | -45.0% | 53,200 | +1.9% | 0.00% | -50.0% |
Q4 2021 | $60,000 | -28.6% | 52,200 | +10.6% | 0.00% | -33.3% |
Q3 2021 | $84,000 | +7.7% | 47,200 | +34.9% | 0.01% | +20.0% |
Q2 2021 | $78,000 | -33.3% | 35,000 | +75.0% | 0.01% | -44.4% |
Q1 2021 | $117,000 | +105.3% | 20,000 | 0.0% | 0.01% | +80.0% |
Q4 2020 | $57,000 | +216.7% | 20,000 | 0.0% | 0.01% | +150.0% |
Q3 2020 | $18,000 | -14.3% | 20,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $21,000 | +40.0% | 20,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $15,000 | -6.2% | 20,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $16,000 | +14.3% | 20,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $14,000 | -17.6% | 20,000 | +100.0% | 0.00% | -33.3% |
Q2 2019 | $17,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |